ArticleClinical pharmacology in drug development2015

Intravenous Pharmacokinetics, Local Tolerability, and Hemolysis of an SBE7-β-Cyclodextrin Formulation of the Neurokinin-1 Receptor Antagonist Vestipitant.

Richard A Brigandi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.